Download PDF
CC BY-NC-ND 4.0 · Journal of Digestive Endoscopy 2021; 12(04): 183-189
DOI: 10.1055/s-0041-1741515
Research Article

Safety and Efficacy of Early Endotherapy in Management of Pancreatic Ascites: Western Indian Experience.

Mayur G. Gattani 
1   Department of Gastroenterology, Lokmanya Tilak Municipal Medical College & General Hospital, Mumbai, India
,
Shamshersingh G. Chauhan
1   Department of Gastroenterology, Lokmanya Tilak Municipal Medical College & General Hospital, Mumbai, India
,
Pratik R. Sethiya
1   Department of Gastroenterology, Lokmanya Tilak Municipal Medical College & General Hospital, Mumbai, India
,
Pooja C. Chandak
2   Department of Radiology, Lokmanya Tilak Municipal Medical College & General Hospital, Mumbai, India
,
Saiprasad G. Lad
1   Department of Gastroenterology, Lokmanya Tilak Municipal Medical College & General Hospital, Mumbai, India
,
Gaurav K. Singh
1   Department of Gastroenterology, Lokmanya Tilak Municipal Medical College & General Hospital, Mumbai, India
,
Kailash M. Kolhe
1   Department of Gastroenterology, Lokmanya Tilak Municipal Medical College & General Hospital, Mumbai, India
,
Harshad B. Khairnar
1   Department of Gastroenterology, Lokmanya Tilak Municipal Medical College & General Hospital, Mumbai, India
,
Vikas R. Pandey 
1   Department of Gastroenterology, Lokmanya Tilak Municipal Medical College & General Hospital, Mumbai, India
,
Meghraj A. Ingle
1   Department of Gastroenterology, Lokmanya Tilak Municipal Medical College & General Hospital, Mumbai, India
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Background Pancreatic ascites is rare but a known complication of pancreatitis. We aimed to study the timings, safety, and efficacy of therapeutic approaches in its management and the outcomes.

Methods We retrospectively studied patients with pancreatic ascites managed in the past 5 years at a single tertiary care center. Therapeutic approaches included conservative therapy, early endoscopic therapy, and surgery. We used descriptive statistics to summarize characteristics of the study population, and performed univariate and binary logistic regression analyses to compare treatment outcomes.

Results Of the 125 patients screened, 70 (male, 81.4%) were included. Disruption in the pancreatic duct (PD) was seen in 51.4% of patients on magnetic resonance cholangiopancreatography (MRCP) and 73.3% of patients on endoscopic retrograde cholangiopancreatography (ERCP). The PD in the body region (46.7%) was the most frequent site of disruption. Early endotherapy included a stent bridging the disruption site in 63.3% of patients and sphincterotomy in 76.7% of patients with a median time to ERCP from symptom onset being 8.5 days. The success rate in early endotherapy was 81.7%, while the recurrence rate was 8%. For conservative therapy only, the success rate was 60% with recurrence in two-thirds. The variables crucial in the success of endotherapy were a partial disruption (p < 0.001), ductal disruption site (p = 0.004), sphincterotomy (p = 0.013), and a bridging stent (p = 0.001). Significant pancreatic necrosis (p < 0.001) and intraductal calculi (p = 0.002) were the factors responsible for failure in endotherapy.

Conclusions Early endotherapy is safe and effective in the treatment of pancreatic ascites. The efficacy of endotherapy is augmented by PD stenting combined with pancreatic sphincterotomy and a bridging stent.

Keywords

cholangiopancreatography - endoscopic retrograde - Magnetic resonance - ascites - pancreatitis - acute necrotizing - sphincterotomy


Publication History

Article published online:
15 January 2022

© 2022. Society of Gastrointestinal Endoscopy of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Larsen M, Kozarek R. Management of pancreatic ductal leaks and fistulae. J Gastroenterol Hepatol 2014; 29 (07) 1360-1370
    CrossrefPubMedGoogle Scholar
  • 2 Bracher GA, Manocha AP, DeBanto JR. et al. Endoscopic pancreatic duct stenting to treat pancreatic ascites. Gastrointest Endosc 1999; 49 (06) 710-715
    CrossrefPubMedGoogle Scholar
  • 3 Sankaran S, Walt AJ. Pancreatic ascites: recognition and management. Arch Surg 1976; 111 (04) 430-434
    CrossrefPubMedGoogle Scholar
  • 4 Cameron JL. Chronic pancreatic ascites and pancreatic pleural effusions. Gastroenterology 1978; 74 (01) 134-140
    CrossrefPubMedGoogle Scholar
  • 5 Samanta J, Rana A, Dhaka N. et al. Ascites in acute pancreatitis: not a silent bystander. Pancreatology 2019; 19 (05) 646-652
    CrossrefPubMedGoogle Scholar
  • 6 Baretti M, Pulluri B, Tsai HL. et al. The significance of ascites in patients with pancreatic ductal adenocarcinoma: a case-control study. Pancreas 2019; 48 (04) 585-589
    CrossrefPubMedGoogle Scholar
  • 7 Rana SS, Sharma RK, Gupta R. Endoscopic management of pancreatic ascites due to duct disruption following acute necrotizing pancreatitis. JGH Open 2018; 3 (02) 111-116
    CrossrefPubMedGoogle Scholar
  • 8 Jang JW, Kim MH, Oh D. et al. Factors and outcomes associated with pancreatic duct disruption in patients with acute necrotizing pancreatitis. Pancreatology 2016; 16 (06) 958-965
    CrossrefPubMedGoogle Scholar
  • 9 Bakker OJ, van Baal MC, van Santvoort HC. et al; Dutch Pancreatitis Study Group. Endoscopic transpapillary stenting or conservative treatment for pancreatic fistulas in necrotizing pancreatitis: multicenter series and literature review. Ann Surg 2011; 253 (05) 961-967
    CrossrefPubMedGoogle Scholar
  • 10 van Dijk SM, Timmerhuis HC, Verdonk RC. et al; Dutch Pancreatitis Study Group. Treatment of disrupted and disconnected pancreatic duct in necrotizing pancreatitis: a systematic review and meta-analysis. Pancreatology 2019; 19 (07) 905-915
    CrossrefPubMedGoogle Scholar
  • 11 Tanaka T, Kuroki T, Kitasato A. et al. Endoscopic transpapillary pancreatic stenting for internal pancreatic fistula with the disruption of the pancreatic ductal system. Pancreatology 2013; 13 (06) 621-624
    CrossrefPubMedGoogle Scholar
  • 12 Bhasin DK, Rana SS, Siyad I. et al. Endoscopic transpapillary nasopancreatic drainage alone to treat pancreatic ascites and pleural effusion. J Gastroenterol Hepatol 2006; 21 (06) 1059-1064
    CrossrefPubMedGoogle Scholar
  • 13 Banks PA, Bollen TL, Dervenis C. et al; Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62 (01) 102-111
    CrossrefPubMedGoogle Scholar
  • 14 Bassi C, Dervenis C, Butturini G. et al; International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005; 138 (01) 8-13
    CrossrefPubMedGoogle Scholar
  • 15 Drake LM, Anis M, Lawrence C. Accuracy of magnetic resonance cholangiopancreatography in identifying pancreatic duct disruption. J Clin Gastroenterol 2012; 46 (08) 696-699
    CrossrefPubMedGoogle Scholar
  • 16 Timmerhuis HC, van Dijk SM, Verdonk RC. et al. Various modalities accurate in diagnosing a disrupted or disconnected pancreatic duct in acute pancreatitis: a systematic review. Dig Dis Sci 2020; 66 (05) 1415-1424
    CrossrefPubMedGoogle Scholar
  • 17 Mortele KJ, Wiesner W, Intriere L. et al. A modified CT severity index for evaluating acute pancreatitis: improved correlation with patient outcome. Am J Roentgenol 2004; 183 (05) 1261-1265
    CrossrefPubMedGoogle Scholar
  • 18 Varadarajulu S, Noone TC, Tutuian R, Hawes RH, Cotton PB. Predictors of outcome in pancreatic duct disruption managed by endoscopic transpapillary stent placement. Gastrointest Endosc 2005; 61 (04) 568-575
    CrossrefPubMedGoogle Scholar
  • 19 Cotton PB, Lehman G, Vennes J. et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37 (03) 383-393
    CrossrefPubMedGoogle Scholar
  • 20 O'Toole D, Vullierme MP, Ponsot P. et al. Diagnosis and management of pancreatic fistulae resulting in pancreatic ascites or pleural effusions in the era of helical CT and magnetic resonance imaging. Gastroenterol Clin Biol 2007; 31 (8-9 Pt 1): 686-693
    CrossrefPubMedGoogle Scholar
  • 21 Soto JA, Alvarez O, Múnera F, Yepes NL, Sepúlveda ME, Pérez JM. Traumatic disruption of the pancreatic duct: diagnosis with MR pancreatography. Am J Roentgenol 2001; 176 (01) 175-178
    CrossrefPubMedGoogle Scholar
  • 22 Panda A, Kumar A, Gamanagatti S. et al. Evaluation of diagnostic utility of multidetector computed tomography and magnetic resonance imaging in blunt pancreatic trauma: a prospective study. Acta Radiol 2015; 56 (04) 387-396
    CrossrefPubMedGoogle Scholar
  • 23 Subramanian A, Dente CJ, Feliciano DV. The management of pancreatic trauma in the modern era. Surg Clin North Am 2007; 87 (06) 1515-1532 , x
    CrossrefPubMedGoogle Scholar
  • 24 Fernández-Cruz L, Margarona E, Llovera J, López-Boado MA, Saenz H. Pancreatic ascites. Hepatogastroenterology 1993; 40 (02) 150-154
    PubMedGoogle Scholar
  • 25 Gislason H, Grønbech JE, Søreide O. Pancreatic ascites: treatment by continuous somatostatin infusion. Am J Gastroenterol 1991; 86 (04) 519-521
    PubMedGoogle Scholar
  • 26 Parekh D, Segal I. Pancreatic ascites and effusion. Risk factors for failure of conservative therapy and the role of octreotide. Arch Surg 1992; 127 (06) 707-712
    CrossrefPubMedGoogle Scholar
  • 27 Kurumboor P, Varma D, Rajan M. et al. Outcome of pancreatic ascites in patients with tropical calcific pancreatitis managed using a uniform treatment protocol. Indian J Gastroenterol 2009; 28 (03) 102-106
    CrossrefPubMedGoogle Scholar
  • 28 Chebli JMF, Gaburri PD, de Souza AF. et al. Internal pancreatic fistulas: proposal of a management algorithm based on a case series analysis. J Clin Gastroenterol 2004; 38 (09) 795-800
    CrossrefPubMedGoogle Scholar
  • 29 Pai CG, Suvarna D, Bhat G. Endoscopic treatment as first-line therapy for pancreatic ascites and pleural effusion. J Gastroenterol Hepatol 2009; 24 (07) 1198-1202
    CrossrefPubMedGoogle Scholar
  • 30 Gupta S, Gaikwad N, Samarth A, Sawalakhe N, Sankalecha T. Efficacy of pancreatic endotherapy in pancreatic ascites and pleural effusion. Med Sci (Basel) 2017; 5 (02) 6
    CrossrefPubMedGoogle Scholar
  • 31 Neoptolemos JP, London NJ, Carr-Locke DL. Assessment of main pancreatic duct integrity by endoscopic retrograde pancreatography in patients with acute pancreatitis. Br J Surg 1993; 80 (01) 94-99
    CrossrefPubMedGoogle Scholar
  • 32 Yokoi Y, Kikuyama M, Kurokami T, Sato T. Early dual drainage combining transpapillary endotherapy and percutaneous catheter drainage in patients with pancreatic fistula associated with severe acute pancreatitis. Pancreatology 2016; 16 (04) 497-507
    CrossrefPubMedGoogle Scholar
  • 33 da Cunha JE, Machado M, Bacchella T. et al. Surgical treatment of pancreatic ascites and pancreatic pleural effusions. Hepatogastroenterology 1995; 42 (05) 748-751
    PubMedGoogle Scholar
  • 34 Selvakumar E, Vimalraj V, Rajendran S. et al. Pancreaticogastrostomy for pancreatic ascites. Hepatogastroenterology 2007; 54 (75) 657-660
    PubMedGoogle Scholar
  • 35 Alexakis N, Sutton R, Neoptolemos JP. Surgical treatment of pancreatic fistula. Dig Surg 2004; 21 (04) 262-274
    CrossrefPubMedGoogle Scholar
  • 36 Kaman L, Behera A, Singh R, Katariya RN. Internal pancreatic fistulas with pancreatic ascites and pancreatic pleural effusions: recognition and management. ANZ J Surg 2001; 71 (04) 221-225
    CrossrefPubMedGoogle Scholar